ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,13862
0,00%
Bitcoin
68.395,80
-1,26%
Brent Oil
81,93
-0,04%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Metacrine Inc (MTCR)

  7. Metacrine Inc (MTCR) Notícias

MTCR

Metacrine (MTCR)

Metacrine Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MTCR
DataHoraFonteTítuloCódigoCompanhia
23/03/202317:36Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MTCRMetacrine Inc
23/03/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTCRMetacrine Inc
08/03/202308:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MTCRMetacrine Inc
03/03/202319:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MTCRMetacrine Inc
03/03/202312:45Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:MTCRMetacrine Inc
14/02/202318:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTCRMetacrine Inc
13/02/202310:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MTCRMetacrine Inc
27/01/202318:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MTCRMetacrine Inc
24/01/202319:18Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:MTCRMetacrine Inc
23/12/202218:01GlobeNewswire Inc.Metacrine and Equillium Mutually Agree to Terminate Definitive Merger AgreementNASDAQ:MTCRMetacrine Inc
19/12/202218:00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MTCRMetacrine Inc
15/12/202208:42Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MTCRMetacrine Inc
08/12/202214:09Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:MTCRMetacrine Inc
16/11/202208:25TipRanksMetacrine (MTCR) Receives a Hold from H.C. WainwrightNASDAQ:MTCRMetacrine Inc
14/11/202218:49Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MTCRMetacrine Inc
14/11/202218:41Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTCRMetacrine Inc
14/11/202218:38GlobeNewswire Inc.Metacrine Reports Third-Quarter 2022 ResultsNASDAQ:MTCRMetacrine Inc
10/11/202218:22Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:MTCRMetacrine Inc
06/09/202217:00Business WireEquillium to Acquire Metacrine in All-Stock TransactionNASDAQ:MTCRMetacrine Inc
15/08/202207:36TipRanksH.C. Wainwright Remains a Hold on Metacrine (MTCR)NASDAQ:MTCRMetacrine Inc
09/08/202217:05GlobeNewswire Inc.Metacrine Reports Second-Quarter 2022 ResultsNASDAQ:MTCRMetacrine Inc
13/05/202207:37TipRanksH.C. Wainwright Maintains Their Hold Rating on Metacrine (MTCR)NASDAQ:MTCRMetacrine Inc
12/05/202217:05GlobeNewswire Inc.Metacrine Reports First-Quarter 2022 ResultsNASDAQ:MTCRMetacrine Inc
03/04/202207:46TipRanksMetacrine (MTCR) Gets a Hold Rating from RBC CapitalNASDAQ:MTCRMetacrine Inc
01/04/202207:16TipRanksH.C. Wainwright Maintains a Hold Rating on Metacrine (MTCR)NASDAQ:MTCRMetacrine Inc
30/03/202217:19Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MTCRMetacrine Inc
30/03/202217:05GlobeNewswire Inc.Metacrine Reports Fourth-Quarter 2021 ResultsNASDAQ:MTCRMetacrine Inc
24/02/202218:05GlobeNewswire Inc.Metacrine Announces Executive Leadership ChangesNASDAQ:MTCRMetacrine Inc
11/02/202210:05GlobeNewswire Inc.Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring PlanNASDAQ:MTCRMetacrine Inc
18/01/202222:51TipRanksRBC Capital Sticks to Its Hold Rating for Metacrine (MTCR)NASDAQ:MTCRMetacrine Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MTCR

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
POSI3
POSITIVO TEC ON
BOV
PDTC3
Padtec ON
BOV
COGN3
COGNA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados